Skip to main content

Pharmacy

By Kaiser Health News | 03:57 pm | February 25, 2016
Most of the people running for president say they want to do something about the rising cost of prescription drugs. But most of their proposals probably won't work because they don't address the dynamics behind these price increases.
By Kaiser Health News | 05:41 am | February 19, 2016
Medicare beneficiaries who live in urban areas may save money on their prescription drugs this year because they have better access to pharmacies in drug plan networks that charge lower copayments or coinsurance, according to the federal Centers for Medicare & Medicaid Services.
By Jeff Lagasse | 10:19 am | February 17, 2016
Prescription drug spending in the U.S. rose 12 percent in 2014, reaching nearly $300 billion, the latest issue of the Journal of Managed Care and Specialty Pharmacy showed.
By Jeff Lagasse | 04:07 pm | February 09, 2016
While the medical importance of vaccines is largely known, a pair of researchers is looking to define just what economic value vaccines play in the realm of global healthcare.
By Susan Morse | 11:04 am | February 04, 2016
Former Turing CEO Martin Shkreli on Thursday invoked his Fifth Amendment rights while members of a Congressional committee grilled pharmaceutical executives about the high price of prescription drugs.
By Bernie Monegain | 08:52 am | February 03, 2016
Cincinnati, Ohio-based Mercy Health has saved more than $42 million on drugs since 2010 by building a formulary within its electronic health record platform.
By Kaiser Health News | 08:29 am | January 29, 2016
California voters will weigh in this November on a high-stakes ballot proposition intended to help control the cost of prescription drugs - the latest attempt to limit soaring prices that have prompted public criticism nationwide.
By Susan Morse | 10:51 am | January 26, 2016
Donald Trump is calling for a change in the way Medicare deals with big pharma prices, a revision long targeted by Democrats.
By Jeff Lagasse | 10:08 am | January 26, 2016
Biopharmaceutical company Emmaus Life Sciences has raised approximately $1.7 million in gross proceeds from the sale of common shares to Korea Bio Medical Science Institute as part of a collaboration agreement between the two companies.
By Jeff Lagasse | 03:13 pm | January 25, 2016
The United States Department of Justice has given its blessing to a district court in New York to allow ex-pharmaceutical CEO Martin Shkreli to travel to Washington, D.C. to testify at a hearing on drug pricing on February 4.